SkinBio Therapeutics' IPO

SkinBio Therapeutics raised a round of funding on March 23, 2017. Investors include Public.

SkinBioTherapeutics (AIM:SBTX) is a life science company focused on skin health. The SkinBioTherapeutics' platform applies research discoveries made on the activities of lysates derived from probiotic…

Articles about SkinBio Therapeutics' IPO: